Clinical Trial Update: Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of the fluorine-18 FP-CIT PET tracer in patients with Parkinson's disease and essential tremor has been complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor
• Parkinson Disease

Drugs mentioned

• F-18 FP-CIT PET tracer (Fluorine-18 FP-CIT)

Snippet

Sponsor: Asan Medical Center | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED